DXCM financial statements and SEC filings
DXCM annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $4.66B | $911.80M | $836.30M | 10-K |
| 2024-12-31 | $4.03B | $600.00M | $576.20M | 10-K |
| 2023-12-31 | $3.62B | $597.70M | $541.50M | 10-K |
| 2022-12-31 | $2.91B | $391.20M | $341.20M | 10-K |
| 2021-12-31 | $2.45B | $265.80M | $216.90M | 10-K |
| 2020-12-31 | $1.93B | $299.50M | $549.70M | 10-K |
DXCM annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $6.34B | $3.59B | $2.75B | 10-Q |
| 2024-12-31 | $6.48B | $4.38B | $2.10B | 10-K |
| 2023-12-31 | $6.26B | $4.20B | $2.07B | 10-K |
| 2022-12-31 | $5.39B | $3.26B | $2.13B | 10-K |
| 2021-12-31 | $4.93B | $2.89B | $2.04B | 10-K |
| 2020-12-31 | $4.29B | $2.46B | $1.83B | 10-K |
DXCM annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $1.44B | -$363.50M | -$1.69B | 10-K |
| 2024-12-31 | $989.50M | -$358.80M | -$734.80M | 10-K |
| 2023-12-31 | $748.50M | -$236.60M | -$318.60M | 10-K |
| 2022-12-31 | $669.50M | -$364.80M | -$552.50M | 10-K |
| 2021-12-31 | $442.50M | -$389.20M | $10.40M | 10-K |
| 2020-12-31 | $475.60M | -$199.00M | $912.10M | 10-K |